practice

A drug shortage list becomes useful only when it is connected to affected residents and decisions

FDA maintains current, resolved, and discontinued shortage information. A consultant practice can turn that external signal into a controlled resident and facility workflow without improvising substitutions.

Pharmacy team reviewing a supply issue and resident worklist
Shortage monitoring needs a route from product signal to resident-specific clinical decision.

Confirm the exact shortage signal

Start with FDA's record and inspect ingredient, dosage form, strength, presentation, company information, availability, and update date. Also verify the dispensing pharmacy's actual supply situation.

A national listing does not establish that every presentation is unavailable to every pharmacy. Likewise, a local problem may appear before a broad public status changes.

Map impact without prescribing from a spreadsheet

Identify potentially affected residents and facilities, then route the list to the responsible dispensing and clinical teams. Include current product detail and timing, but do not encode an unapproved substitute as if it were an order.

Track the question, decision owner, response, and whether documentation or monitoring needs change. Keep urgent operational communication separate from routine MRR batching.

Close the loop when status changes

Resolved does not necessarily mean every local channel has stock immediately. Reconfirm supply and review any temporary therapies or monitoring plans created during the shortage.

Afterward, note where resident identification or communication failed. That improvement is the durable value of the exercise.